Education
About Us
Working with TipRanks
Follow Us
Viatris, Inc. (DE:VIA)
:VIA
Earnings Data
Report Date
Feb 27, 2025TBA Not Confirmed
Period Ending
2024 (Q4)Consensus EPS Forecast
0.54Last Year’s EPS
0.59Same Quarter Last Year
Moderate Buy
Based on 3 Analysts Ratings
---
Earnings Call Summary
Earnings Call Date:Nov 07, 2024
|% Change Since: 0.05%
|Next Earnings Date:Feb 27, 2025
Earnings Call Sentiment|Positive
The earnings call reflected a strong financial performance with consistent operational revenue growth and strategic debt reduction. The company is focused on expanding its innovative portfolio, particularly in cardiovascular and ophthalmology sectors. While there are challenges related to the ARV generics supply chain and certain brand declines, the overall outlook remains positive with plans for shareholder value maximization and disciplined business development.Company Guidance
During the Viatris Q3 2024 earnings call, the company provided guidance for the year, highlighting several key financial metrics. They reported total revenues of $3.8 billion, marking an operational revenue growth of approximately 3%, with adjusted EBITDA rising by 4% to $1.3 billion and adjusted EPS increasing by 6% to $0.75 per share. Free cash flow was reported at $866 million, excluding transaction costs and taxes. Additionally, Viatris repaid approximately $1.9 billion in debt, moving closer to their long-term gross leverage target. For 2025, the company anticipates continuing momentum in base business growth and aims to be more aggressive with share buybacks, leveraging their current valuation level. New product revenues were strong, with $133 million reported in the quarter, and the company expects to achieve the higher end of their $500 million to $600 million range for the year. Looking forward, Viatris reaffirmed their 2024 outlook, projecting base business operational revenue growth of approximately 2% and flat adjusted EBITDA and EPS compared to the previous year.Consistent Operational Revenue Growth
Achieved sixth consecutive quarter of operational revenue growth with total revenues of $3.8 billion, representing approximately 3% growth.
Strong Financial Performance
Adjusted EBITDA grew by approximately 4% year-over-year, and adjusted EPS increased by approximately 6%.
Debt Reduction and Financial Strategy
Repaid approximately $1.9 billion in debt, focusing on achieving a long-term gross leverage target, and planning to return value to shareholders through dividends and share repurchases.
Expansion in Cardiovascular Portfolio
Entered an exclusive licensing agreement with Lexicon Pharmaceuticals for sotaliclosin, expanding the cardiovascular portfolio with approximately $2.5 billion in annual revenue.
New Product Revenue and Pipeline Growth
Delivered strong new product revenues of $133 million in the quarter, with a focus on further expanding the innovative pipeline, including ophthalmology and cardiovascular programs.
---
DE:VIA Earnings History
The table shows recent earnings report dates and whether the forecast was beat or missed. See the change in forecast and EPS from the previous year.
Beat
Missed
---
DE:VIA Earnings-Related Price Changes
Report Date | Price 1 Day Before | Price 1 Day After | Percentage Change |
|---|---|---|---|
| Feb 27, 2025 | €10.81 | €9.03 | -16.49% |
| Nov 07, 2024 | €10.87 | €11.95 | +9.99% |
| Aug 08, 2024 | €10.24 | €11.29 | +10.30% |
| May 09, 2024 | €10.78 | €10.13 | -6.00% |
Earnings announcements can affect a stock’s price. This table shows the stock's price the day before and the day after recent earnings reports, including the percentage change.
---
FAQ
When does Viatris, Inc. (DE:VIA) report earnings?
Viatris, Inc. (DE:VIA) is schdueled to report earning on Feb 27, 2025, TBA Not Confirmed.
What is Viatris, Inc. (DE:VIA) earnings time?
Viatris, Inc. (DE:VIA) earnings time is at Feb 27, 2025, TBA Not Confirmed.
Where can I see when companies are reporting earnings?
You can see which companies are reporting today on our designated earnings calendar.
What companies are reporting earnings today?
You can see a list of the companies which are reporting today on TipRanks earnings calendar.
What is the P/E ratio of Viatris, Inc. stock?
The P/E ratio of Viatris is N/A.
What is DE:VIA EPS forecast?
DE:VIA EPS forecast for the fiscal quarter 2024 (Q4) is 0.54.
---
